Last reviewed · How we verify

NCT05071755: GOE

Gastrectomy Outcomes in Elderly Patients

Status unknown Last updated 19 October 2021
What this trial tests

trial testing Gastrectomy in Gastrectomy in 350 participants. Status unknown.

Timeline
1 November 2021
Primary endpoint
1 February 2022
1 March 2022

Quick facts

Lead sponsorMarmara University
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment350
Start date1 November 2021
Primary completion1 February 2022
Estimated completion1 March 2022
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Marmara University

Who can join

Adults 65 to 100, any sex, with Gastrectomy or Elderly. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this study, the investigators aimed to identify independent prognostic factors for early postoperative complications and survival in elderly patients (aged ≥65 years) with gastric cancer.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Gastrectomy

Trials testing the same drug.

Other recruiting trials for Gastrectomy

Currently open trials in the same condition.

Other Marmara University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05071755.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing